Robert Schierwagen

5.4k total citations
91 papers, 2.3k citations indexed

About

Robert Schierwagen is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Robert Schierwagen has authored 91 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Epidemiology, 67 papers in Hepatology and 24 papers in Surgery. Recurrent topics in Robert Schierwagen's work include Liver Disease Diagnosis and Treatment (70 papers), Liver Disease and Transplantation (50 papers) and Liver physiology and pathology (23 papers). Robert Schierwagen is often cited by papers focused on Liver Disease Diagnosis and Treatment (70 papers), Liver Disease and Transplantation (50 papers) and Liver physiology and pathology (23 papers). Robert Schierwagen collaborates with scholars based in Germany, Spain and Denmark. Robert Schierwagen's co-authors include Jonel Trebicka, Sabine Klein, Frank Erhard Uschner, Tilman Sauerbruch, Christian P. Strassburg, M Granzow, Christian Jansen, Kanishka Hittatiya, Jennifer Lehmann and Fernando Magdaleno and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Robert Schierwagen

89 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Schierwagen Germany 29 1.4k 1.2k 491 466 185 91 2.3k
Sabine Klein Germany 28 1.6k 1.1× 1.4k 1.1× 512 1.0× 467 1.0× 122 0.7× 70 2.4k
Hirotoshi Ebinuma Japan 29 1.2k 0.9× 1.1k 0.9× 563 1.1× 579 1.2× 161 0.9× 148 2.8k
Xavier Verhelst Belgium 25 898 0.6× 692 0.6× 425 0.9× 439 0.9× 144 0.8× 104 1.8k
Meena B. Bansal United States 24 1.6k 1.1× 1.2k 1.0× 379 0.8× 338 0.7× 74 0.4× 73 2.5k
José Altamirano Spain 28 1.9k 1.3× 1.1k 0.9× 503 1.0× 400 0.9× 126 0.7× 59 2.9k
Jung Woo Shin South Korea 25 959 0.7× 826 0.7× 449 0.9× 500 1.1× 202 1.1× 108 2.3k
Christophe Van Steenkiste Belgium 23 844 0.6× 720 0.6× 344 0.7× 436 0.9× 159 0.9× 68 1.6k
Masahito Minami Japan 33 1.8k 1.3× 1.4k 1.1× 291 0.6× 577 1.2× 210 1.1× 71 2.8k
Yuemin Nan China 23 997 0.7× 670 0.5× 180 0.4× 508 1.1× 255 1.4× 117 1.6k
Ariel E. Feldstein United States 15 958 0.7× 544 0.4× 237 0.5× 680 1.5× 106 0.6× 23 1.7k

Countries citing papers authored by Robert Schierwagen

Since Specialization
Citations

This map shows the geographic impact of Robert Schierwagen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Schierwagen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Schierwagen more than expected).

Fields of papers citing papers by Robert Schierwagen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Schierwagen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Schierwagen. The network helps show where Robert Schierwagen may publish in the future.

Co-authorship network of co-authors of Robert Schierwagen

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Schierwagen. A scholar is included among the top collaborators of Robert Schierwagen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Schierwagen. Robert Schierwagen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brol, Maximilian Joseph, Lila Close, Robert Schierwagen, et al.. (2025). Lactococcus A phages predict ACLF while Enterococcus B phages predict bacterial infection in decompensated cirrhosis. JHEP Reports. 8(1). 101622–101622.
2.
Drebber, Uta, Robert Schierwagen, Wen Gu, et al.. (2024). Stage of fibrosis is not a predictive determinant of weight loss in patients undergoing bariatric surgery. Surgery for Obesity and Related Diseases. 20(8). 759–766. 1 indexed citations
3.
Hartmann, Phillipp, Sonja Lang, Robert Schierwagen, et al.. (2023). Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failure. Hepatobiliary & pancreatic diseases international. 22(5). 474–481. 7 indexed citations
4.
Wirtz, Stefan, Klaus Weber, Axel Denz, et al.. (2023). Colon Cancer Microbiome Landscaping: Differences in Right- and Left-Sided Colon Cancer and a Tumor Microbiome-Ileal Microbiome Association. International Journal of Molecular Sciences. 24(4). 3265–3265. 22 indexed citations
5.
Ruiz‐Margáin, Astrid, Alessandra Pohlmann, Melanie Langheinrich, et al.. (2023). Myostatin is associated with the presence and development of acute-on-chronic liver failure. JHEP Reports. 5(8). 100761–100761. 8 indexed citations
6.
Drebber, Uta, Robert Schierwagen, Wen Gu, et al.. (2023). Stage of fibrosis is not a predictive determinant of weight loss in patients undergoing bariatric surgery. Zeitschrift für Gastroenterologie. 61(1). e16–e16. 1 indexed citations
7.
Sauerbruch, Tilman, Martin Hennenberg, Jonel Trebicka, & Robert Schierwagen. (2023). Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?. Frontiers in Medicine. 9. 1100966–1100966. 8 indexed citations
8.
Niu, Lili, Philipp E. Geyer, Rajat Gupta, et al.. (2022). Dynamic human liver proteome atlas reveals functional insights into disease pathways. Molecular Systems Biology. 18(5). e10947–e10947. 27 indexed citations
9.
Torres, Sandra, Maximilian Joseph Brol, Fernando Magdaleno, et al.. (2021). The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis. Frontiers in Molecular Biosciences. 8. 715765–715765. 22 indexed citations
10.
Blaya, Delia, Elisa Pose, Mar Coll, et al.. (2021). Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure. JHEP Reports. 3(2). 100233–100233. 16 indexed citations
11.
Luetkens, Julian A., Sabine Klein, Frank Träber, et al.. (2019). Quantification of liver fibrosis: extracellular volume fraction using an MRI bolus-only technique in a rat animal model. European Radiology Experimental. 3(1). 22–22. 13 indexed citations
12.
Uschner, Frank Erhard, Sabine Klein, Robert Schierwagen, et al.. (2018). The multikinase inhibitor regorafenib decreases angiogenesis and improves portal hypertension. Oncotarget. 9(90). 36220–36237. 24 indexed citations
13.
Jansen, Christian, Philipp T. Möller, Carsten H. Meyer, et al.. (2017). Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality. Hepatology. 67(4). 1472–1484. 61 indexed citations
14.
Beiert, Thomas, Vedat Tiyerili, Markus Linhart, et al.. (2017). Relaxin reduces susceptibility to post-infarct atrial fibrillation in mice due to anti-fibrotic and anti-inflammatory properties. Biochemical and Biophysical Research Communications. 490(3). 643–649. 24 indexed citations
15.
Beiert, Thomas, Vedat Tiyerili, Florian Stöckigt, et al.. (2017). Chronic lower-dose relaxin administration protects from arrhythmia in experimental myocardial infarction due to anti-inflammatory and anti-fibrotic properties. International Journal of Cardiology. 250. 21–28. 22 indexed citations
16.
Klein, Sabine, Kanishka Hittatiya, Robert Schierwagen, et al.. (2016). Novel Rat Model of Repetitive Portal Venous Embolization Mimicking Human Non-Cirrhotic Idiopathic Portal Hypertension. PLoS ONE. 11(9). e0162144–e0162144. 16 indexed citations
17.
Fialla, Annette Dam, Robert Schierwagen, Matteo Biagini, et al.. (2016). The calcium-activated potassium channel KCa3.1 is an important modulator of hepatic injury. Scientific Reports. 6(1). 28770–28770. 24 indexed citations
18.
Klein, Sabine, Jennifer Lehmann, Robert Schierwagen, et al.. (2015). Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis. Gut. 66(1). 145–155. 55 indexed citations
19.
Schierwagen, Robert, Diana Julie Leeming, Sabine Klein, et al.. (2013). Serum markers of the extracellular matrix remodeling reflect antifibrotic therapy in bile-duct ligated rats. Frontiers in Physiology. 4. 195–195. 28 indexed citations
20.
Grace, Josephine, Sabine Klein, Chandana B. Herath, et al.. (2013). Activation of the Mas Receptor by Angiotensin-(1–7) in the Renin–Angiotensin System Mediates Mesenteric Vasodilatation in Cirrhosis. Gastroenterology. 145(4). 874–884.e5. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabine Klein Breakdown of academic impact, for papers by Hirotoshi Ebinuma Breakdown of academic impact, for papers by Xavier Verhelst Breakdown of academic impact, for papers by Meena B. Bansal Breakdown of academic impact, for papers by José Altamirano Breakdown of academic impact, for papers by Jung Woo Shin Breakdown of academic impact, for papers by Christophe Van Steenkiste Breakdown of academic impact, for papers by Masahito Minami Breakdown of academic impact, for papers by Yuemin Nan Breakdown of academic impact, for papers by Ariel E. Feldstein
Rankless by CCL
2026